Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Opsona Therapeutics

Opsona Therapeutics

Developer of novel therapeutic approaches designed to focus on the treatment of autoimmune or inflammatory diseases and cancers. The company's approaches targets the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease and atherosclerosis, enabling healthcare providers to cure their patients.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Second Floor, Ashford House
  • Tara Street
  • Dublin 2
  • Ireland

+353 (01) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Opsona Therapeutics’s full profile, request a free trial.

Opsona Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Bankruptcy: Liquidation 13-Jan-2019 00000 Completed Bankruptcy: Liquidation
8. Later Stage VC (Series F) 26-Aug-2018 00.000 00000 Completed Clinical Trials - Phase 2
7. Later Stage VC 03-Feb-2017 000.00 00000 Completed Clinical Trials - Phase 2
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Later Stage VC 01-Mar-2014 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 02-Oct-2013 000.00 000.00 Completed Generating Revenue
3. Grant 06-May-2011 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 19-May-2009 $28.5M $36.6M Completed Startup
1. Early Stage VC (Series A) 24-Feb-2005 $8.12M $8.12M Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Opsona Therapeutics Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apitope International Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
0000000 0000000000 Formerly VC-backed Waltham, MA 00 00000 00000000 00000
0000000000 Corporate Backed or Acquired Basel, Switzerland 000000&0
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
To view this company’s complete list of competitors, request access »